Field of the Disclosure
The present disclosure relates to the field of neurological treatment and rehabilitation for injury and disease including traumatic spinal cord injury, non-traumatic spinal cord injury, stroke, movement disorders, brain injury, ALS, Neurodegenerative Disorder, Dementia, Parkinson's disease, and other diseases or injuries that result in paralysis and/or nervous system disorder. Devices, pharmacological agents, and methods are provided to facilitate recovery of posture, locomotion, and voluntary movements of the arms, trunk, and legs, and recovery of autonomic, sexual, vasomotor, speech, swallowing, and respiration, in a human subject having spinal cord injury, brain injury, or any other neurological disorder.
Description of the Related Art
Serious spinal cord injuries (SCI) affect approximately 1.3 million people in the United States, and roughly 12-15,000 new injuries occur each year. Of these injuries, approximately 50% are complete spinal cord injuries in which there is essentially total loss of sensory motor function below the level of the spinal lesion.
Neuronal networks formed by the interneurons of the spinal cord that are located in the cervical and lumbar enlargements, such as the spinal networks (SNs), play an important role in the control of posture, locomotion and movements of the upper limbs, breathing and speech. Most researchers believe that all mammals, including humans, have SNs in the lumbosacral cord. See Dimitrijevic, M. R, Gerasimenko, Yu., and Pinter, M. M., Evidence for a Spinal Central Pattern Generator in Humans, Ann. N. Y. Acad. Sci., 1998, vol. 860, p. 360; Gurfinkel', V. S., Levik, Yu. S., Kazennikov, O. V., and Selionov, V. A., Does the Prime Mover of Stepping Movements Exist in Humans?, Human Physiology, 1998, vol. 24, no. 3, p. 42; Gerasimenko, Yu. P., Roy, R. R., and Edgerton, V R., Epidural Stimulation: Comparison of the Spinal Circuits That Generate and Control Locomotion in Rats, Cats and Humans, Exp. Neurol., 2008, vol. 209, p. 417. Normally, the activity of SNs is regulated supraspinally and by peripheral sensory input. In the case of disorders of the connections between the brain and spinal cord, e.g., as a result of traumatic spinal cord lesions, motor tasks can be enabled by epidural electrical stimulation of the lumbosacral and cervical segments as well as the brainstem. It has been shown that epidural electrical spinal cord stimulation (eESCS) with sufficient intensity can induce electromyographic (EMG) patterns in the leg muscles of patients with clinically complete spinal cord injury. See Dimitrijevic, Gerasimenko, Yu., and Pinter, supra; Minassian, K., Persy, I., Rattay, F, Pinter, M. M., Kern, H., and Dimitrijevic, M. R., Human Lumbar Cord Circuitries Can Be Activated by Extrinsic Tonic Input to Generate Locomotor-Like Activity, Human 1Hovement Sci., 2007, vol. 26, p. 275; Harkema, S., Gerasimenko, Y, Hodes, J., Burdick, J., Angeli, e., Chen, Y, Ferreira, e., Willhite, A., Rejc, E., Grossman, R. G., and Edgerton, V R., Epidural Stimulation of the Lumbosacral Spinal Cord Enables Voluntary Movement, Standing, and Assisted Stepping in a Paraplegic Human, Lancet, 2011, vol. 377, p. 1938. eESCS is an invasive method and requires surgical implantation of electrodes on the dorsal surface of the spinal cord, which limits this method of activating SNs to clinics.
Recently, noninvasive methods for activating the SNs by means of leg muscle vibration and spinal cord electromagnetic stimulation was suggested. It was found that the vibration of the tendons of the hip muscles initiates involuntary walking movements in subjects lying on their side with an external support for the legs. See Gurfinkel', VS., Levik, Yu. S., Kazennikov, O. V, and Selionov, V A., Locomotor-Like Movements Evoked by Leg Muscle Vibration in Humans, Eur. J lVeurosci., 1998, vol. 10, p. 1608; Selionov, V A., Ivanenko, Yu. P., Solopova, lA., and Gurfinkel', VS., Tonic Central and Sensory Stimuli Facilitate Involuntary Air-Stepping in Humans, J Neurophysiol., 2009, vol. 101, p. 2847. In addition, electromagnetic stimulation of the rostral segments of the lumbar spinal cord caused involuntary walking movements in healthy subjects in a similar position with a support for the legs. See Gerasimenko, Yu., Gorodnichev, R., Machueva, E., Pivovarova, E., Semenov, D., Savochin, A., Roy, R. R., and Edgerton, V R., Novel and Direct Access to the Human Locomotor Spinal Circuitry, J New'osci., 2010, vol. 30, p. 3700; Gorodnichev, R. M., Machueva, E. M., Pivovarova, E. A., Semenov, D. V, Ivanov, S. M., Savokhin, A. A., Edgerton, V R., and Gerasimenko, Yu. P., A New Method for the Activation of the Locomotor Circuitry in Humans, Hum. Physiol., 2010, vol. 36, no. 6, p. 700. Step-like movements elicited by vibration and electromagnetic stimulation, have apparently a different origin. In the former case, the SN is activated by afferent input mainly due to the activation of muscle receptors, whereas in the latter case, the neuronal locomotor network is affected directly. Each of these methods has its specificity. For example, the vibratory muscle stimulation elicits involuntary locomotor movements only in the hip and knee joints, without the involvement of the ankle. In addition, these characteristic movements could be evoked only in 50% of the subjects. See Selionov, Ivanenko, Solopova, and Gurfinkel', supra. The percentage of subjects in whom the spinal cord electromagnetic stimulation evoked involuntary step like movements was even smaller (10%), although in this case, the kinematic structure of the resultant movements was consistent with the natural random step-like movements to a greater extent than in the case of vibration. See Gerasimenko, Gorodnichev, Machueva, Pivovarova, Semenov, Savochin, Roy, and Edgerton, supra; Gorodnichev, Machueva, Pivovarova, Semenov, Ivanov, Savokhin, Edgerton, and Gerasimenko, supra. In addition, spinal cord electromagnetic stimulation is limited by the technical capabilities of the stimulator. The modem magnetic stimulator used in clinics (e.g., Magstim Rapid) can provide only short-exposure stimulating effects. The electromagnetic stimulator, with the parameters required to elicit step-like movements (5 Hz and 1.5 T), could be sustained for only 15 s.
Embodiments of the disclosure are for use with a mammal including a human who has a spinal cord with at least one selected dysfunctional spinal circuit or other neurologically derived source of control of movement in a portion of the subject's body. It has been shown that transcutaneous electrical spinal cord stimulation (tESCS) applied in the region of the T11-T12 vertebrae with a frequency of 5-40 Hz elicited involuntary step-like movements in healthy subjects with their legs suspended in a gravity-neutral position. The amplitude of evoked step-like movements increased with increasing tESCS frequency. The frequency of evoked step-like movements did not depend on the frequency of tESCS. It was shown that the hip, knee, and ankle joints were involved in the evoked movements. In conclusion, transcutaneous electrical spinal cord stimulation (tESCS) can be used as a noninvasive method in rehabilitation of spinal pathology. By way of non-limiting examples, application of transcutaneous electrical spinal cord stimulation (tESCS) activates spinal locomotor networks (SNs), in part via the dorsal roots and the gray matter of the spinal cord. When activated, the SNs may (a) enable voluntary movement of muscles involved in at least one of standing, stepping, reaching, grasping, voluntarily changing positions of one or both legs, breathing, speech control, voiding the patient's bladder, voiding the patient's bowel, postural activity, and locomotor activity; (b) enable or improve autonomic control of at least one of cardiovascular function, body temperature, and metabolic processes; and/or (c) help facilitate recovery of at least one of an autonomic function, sexual function, or vasomotor function. According to some embodiments, the present disclosure provides that the spinal circuitry is neuromodulated to a physiological state that facilitates or enables the recovery or improved control of movement following some neuromotor dysfunction.
The paralysis may be a motor complete paralysis or a motor incomplete paralysis. The paralysis may have been caused by a spinal cord injury classified as motor complete or motor incomplete. The paralysis may have been caused by an ischemic or traumatic brain injury. The paralysis may have been caused by an ischemic brain injury that resulted from a stroke or acute trauma. By way of another example, the paralysis may have been caused by a neurodegenerative condition affecting the brain and/or spinal cord. The neurodegenerative brain injury may be associated with at least one of Parkinson's disease, Huntington's disease, Alzheimer's, Frontotemporal Dementia, dystonia, ischemic, stroke, amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), and other conditions such as cerebral palsy and Multiple Sclerosis.
By way of non-limiting example, a method includes applying electrical stimulation to a portion of a spinal cord or brainstem of the subject. The electrical stimulation may be applied by a surface electrode(s) that is applied to the skin surface of the subject. Such an electrode may be positioned at, at least one of a thoracic region, a cervical region, a lumbosacral region of the spinal cord and/or the brainstem. The electrical stimulation is delivered at 5-40 Hz at 20-100 mA. While not a requirement, the electrical stimulation may not directly activate muscle cells in the portion of the patient's body having the paralysis. The electrical stimulation may include at least one of tonic stimulation and intermittent stimulation. The electrical stimulation may include simultaneous or sequential stimulation of different regions of the spinal cord.
If the paralysis was caused by a spinal cord injury at a first location along the spinal cord, the electrical stimulation may be applied by an electrode that is on the spinal cord of the patient at a second location below the first location along the spinal cord relative to the patient's brain.
Optionally, the method may include administering one or more neuropharmaceutical agents to the patient. The neuropharmaceutical agents may include at least one of a serotonergic drug, a dopaminergic drug, a noradrenergic drug, a GABAergic drug, and glycinergic drugs. By way of non-limiting examples, the neuropharmaceutical agents may include at least one of 8-OHDPAT, Way 100.635, Quipazine, Ketanserin, SR. 57227A, Ondanesetron, SB 269970, Buspirone, Methoxamine, Prazosin, Clonidine, Yohimbine, SKF-81297, SCH-23390, Quinpirole, and Eticlopride.
The electrical stimulation is defined by a set of parameter values, and activation of the selected spinal circuit may generate a quantifiable result. Optionally, the method may be repeated using electrical stimulation having different sets of parameter values to obtain quantifiable results generated by each repetition of the method. Then, a machine learning method may be executed by at least one computing device. The machine learning method builds a model of a relationship between the electrical stimulation applied to the spinal cord and the quantifiable results generated by activation of the at least one spinal circuit. A new set of parameters may be selected based on the model. By way of a non-limiting example, the machine learning method may implement a Gaussian Process Optimization.
Another exemplary embodiment is a method of enabling one or more functions selected from a group consisting of postural and/or locomotor activity, voluntary movement of leg position when not bearing weight, improved breathing and ventilation, speech control, swallowing, voluntary voiding of the bladder and/or bowel, return of sexual function, autonomic control of cardiovascular function, body temperature control, and normalized metabolic processes, in a human subject having a neurologically derived paralysis. The method includes stimulating the spinal cord of the subject using a surface electrode while subjecting the subject to physical training that exposes the subject to relevant postural proprioceptive signals, locomotor proprioceptive signals, and supraspinal signals. At least one of the stimulation and physical training modulates in real time provoke or incite the electrophysiological properties of spinal circuits in the subject so the spinal circuits are activated by at least one of supraspinal information and proprioceptive information derived from the region of the subject where the selected one or more functions are facilitated.
The region where the selected one or more functions are facilitated may include one or more regions of the spinal cord that control (a) lower limbs; (b) upper limbs and brainstem for controlling speech; (c) the subject's bladder; (d) the subject's bowel and/or other end organ. The physical training may include standing, stepping, sitting down, laying down, reaching, grasping, stabilizing sitting posture, and/or stabilizing standing posture.
The surface electrode may include an array of one or more electrodes stimulated in a monopolar biphasic configuration. Such a surface electrode may be placed over at least one of a lumbosacral portion of the spinal cord, a thoracic portion of the spinal cord, a cervical portion of the spinal cord and/or the brainstem.
The stimulation may include tonic stimulation and/or intermittent stimulation. The stimulation may include simultaneous or sequential stimulation, or combinations thereof, of different spinal cord regions. Optionally, the stimulation pattern may be under control of the subject.
The physical training may include inducing a load bearing positional change in the region of the subject where locomotor activity is to be facilitated. The load bearing positional change in the subject may include standing, stepping, reaching, and/or grasping. The physical training may include robotically guided training.
The method may also include administering one or more neuropharmaceuticals. The neuropharmaceuticals may include at least one of a serotonergic drug, a dopaminergic drug, a noradrenergic drug, a GABAergic drug, and a glycinergic drug.
Another exemplary embodiment is a method that includes placing an electrode on the patient's spinal cord, positioning the patient in a training device configured to assist with physical training that is configured to induce neurological signals in the portion of the patient's body having the paralysis, and applying electrical stimulation to a portion of a spinal cord of the patient, such as a biphasic signal of 30-40 Hz at 85-100 mA.
Another exemplary embodiment is a system that includes a training device configured to assist with physically training of the patient, a surface electrode array configured to be applied on the patient's spinal cord, and a stimulation generator connected to the electrode. When undertaken, the physical training induces neurological signals in the portion of the patient's body having the paralysis. The stimulation generator is configured to apply electrical stimulation to the electrode. Electrophysiological properties of at least one spinal circuit in the patient's spinal cord is modulated by the electrical stimulation and at least one of (1) a first portion of the induced neurological signals and (2) supraspinal signals such that the at least one spinal circuit is at least partially activatable by at least one of (a) the supraspinal signals and (b) a second portion of the induced neurological signals.
Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs.
The term “motor complete” when used with respect to a spinal cord injury indicates that there is no motor function below the lesion, (e.g., no movement can be voluntarily induced in muscles innervated by spinal segments below the spinal lesion.
The term “monopolar stimulation” refers to stimulation between a local electrode and a common distant return electrode.
The term “autonomic function” refers to functions controlled by the peripheral nervous system that are controlled largely below the level of consciousness, and typically involve visceral functions. Illustrative autonomic functions include, but are not limited to control of bowel, bladder, and body temperature.
The term “sexual function” refers to the ability to sustain a penile erection, have an orgasm (male or female), generate viable sperm, and/or undergo an observable physiological change associated with sexual arousal.
It was discovered that transcutaneous electrical stimulation (TCS) of the spinal cord can induce activation locomotor circuitry in a mammal (e.g., in a human or a non-human mammal). It was demonstrated, for example, that continuous tSCS at 5-40 Hz applied paraspinally over T11-T12 vertebrae at 40-70 mA induced involuntary locomotor like stepping movements in subjects with their legs in a gravity-independent position. The increase of frequency of tSCS from 5 to 30 Hz resulted in augmentation of the amplitude of evoked stepping movements. In chronic spinal cats (3 weeks after spinal cord transection at Th8) tSCS at L5 (a frequency of 5 Hz and intensity ranged from 3 to 10 mA) evoked EMG stepping pattern in hindlimb muscles in all (N=4) of tested animals, while locomotor-like movements produced by tSCS were not weight-bearing.
By non-limiting example, transcutaneous electrical stimulation can be applied to facilitate restoration of locomotion and other neurologic function in subjects suffering with spinal cord injury, as well as other neurological injury and illness. Successful application can provide a device for widespread use in rehabilitation of neurologic injury and disease.
In various embodiments, methods, devices, and optional pharmacological agents are provided to facilitate movement in a mammalian subject (e.g., a human) having a spinal cord injury, brain injury, or other neurological disease or injury. In certain embodiments, the methods involve stimulating the spinal cord of the subject using a surface electrode where the stimulation modulates the electrophysiological properties of selected spinal circuits in the subject so they can be activated by proprioceptive derived information and/or input from supraspinal. In various embodiments, the stimulation is typically accompanied by physical training (e.g., movement) of the region where the sensory-motor circuits of the spinal cord are located.
In particular illustrative embodiments, the devices, optional pharmacological agents, and methods described herein stimulate the spinal cord with, e.g., electrodes that modulate the proprioceptive and supraspinal information which controls the lower limbs during standing and/or stepping and/or the upper limbs during reaching and/or grasping conditions. It is the proprioceptive and cutaneous sensory information that guides the activation of the muscles in a coordinated manner and in a manner that accommodates the external conditions, e.g., the amount of loading, speed, and direction of stepping or whether the load is equally dispersed on the two lower limbs, indicating a standing event, alternating loading indicating stepping, or sensing postural adjustments signifying the intent to reach and grasp.
Unlike approaches that involve specific stimulation of motor neurons to directly induce a movement, the methods described herein enable the spinal circuitry to control the movements. More specifically, the devices, optional pharmacological agents, and methods described herein exploit the spinal circuitry and its ability to interpret proprioceptive information and to respond to that proprioceptive information in a functional way. In various embodiments, this is in contrast to other approaches where the actual movement is induced/controlled by direct stimulation (e.g., of particular motor neurons).
In one illustrative embodiment, the subject is fitted with one or more surface electrodes that afford selective stimulation and control capability to select sites, mode(s), and intensity of stimulation via electrodes placed superficially over, for example, the lumbosacral spinal cord and/or cervical spinal cord to facilitate movement of the arms and/or legs of individuals with a severely debilitating neuromotor disorder.
The subject is provided the generator control unit and is fitted with an electrode(s) and then tested to identify the most effective subject specific stimulation paradigms for facilitation of movement (e.g., stepping and standing and/or arm and/or hand movement). Using these stimulation paradigms, the subject practices standing, stepping, reaching, grabbing, breathing, and/or speech therapy in an interactive rehabilitation program while being subject to spinal stimulation.
Depending on the site/type of injury and the locomotor activity it is desired to facilitate, particular spinal stimulation protocols include, but are not limited to, specific stimulation sites along the lumbosacral, thoracic, and/or cervical spinal cord; specific combinations of stimulation sites along the lumbosacral, thoracic, and/or cervical spinal cord; specific stimulation amplitudes; specific stimulation polarities (e.g., monopolar and bipolar stimulation modalities); specific stimulation frequencies; and/or specific stimulation pulse widths.
In various embodiments, the system is designed so that the patient can use and control it in the home environment.
In various embodiments, the approach is not to electrically induce a walking pattern or standing pattern of activation, but to enable/facilitate it so that when the subject manipulates their body position, the spinal cord can receive proprioceptive information from the legs (or arms) that can be readily recognized by the spinal circuitry. Then, the spinal cord knows whether to step or to stand or to do nothing. In other words, this enables the subject to begin stepping or to stand or to reach and grasp when they choose after the stimulation pattern has been initiated.
Moreover, the methods and devices described herein are effective in a spinal cord injured subject that is clinically classified as motor complete; that is, there is no motor function below the lesion. In various embodiments, the specific combination of electrode(s) activated/stimulated and/or the desired stimulation of any one or more electrodes and/or the stimulation amplitude (strength) can be varied in real time, e.g., by the subject. Closed loop control can be embedded in the process by engaging the spinal circuitry as a source of feedback and feedforward processing of proprioceptive input and by voluntarily imposing fine tuning modulation in stimulation parameters based on visual, and/or kinetic, and/or kinematic input from selected body segments.
In various embodiments, the devices, optional pharmacological agents, and methods are designed so that a subject with no voluntary movement capacity can execute effective standing and/or stepping and/or reaching and/or grasping. In addition, the approach described herein can play an important role in facilitating recovery of individuals with severe although not complete injuries.
The approach described herein can provide some basic postural, locomotor and reaching and grasping patterns on their own. However, they are also likely to be a building block for future recovery strategies. Based on certain successes in animals and some preliminary human studies (see below), it appears that a strategy combining effective transcutaneous stimulation of the appropriate spinal circuits with physical rehabilitation and pharmacological intervention can provide practical therapies for complete SCI human patients. There is sufficient evidence from our work that such an approach should be enough to enable weight bearing standing, stepping and/or reaching or grasping. Such capability can give SCI patients with complete paralysis or other neuromotor dysfunctions the ability to participate in exercise, which is known to be highly beneficial for their physical and mental health. We also expect our method should enable movement with the aid of assistive walkers. While far from complete recovery of all movements, even simple standing and short duration walking would increase these patients autonomy and quality of life. The stimulating array technology described herein (e.g., transcutaneous electrical stimulation) paves the way for a direct brain-to-spinal cord interface that could enable more lengthy and finer control of movements.
While the methods and devices described herein are discussed with reference to complete spinal injury, it will be recognized that they can apply to subjects with partial spinal injury, subjects with brain injuries (e.g., ischemia, traumatic brain injury, stroke, and the like), and/or subjects with neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), cerebral palsy, and the like).
In various embodiments, the methods combine the use of transcutaneous stimulating electrode(s) with physical training (e.g., rigorously monitored (robotic) physical training), optionally in combination with pharmacological techniques. The methods enable the spinal cord circuitry to utilize sensory input as well as newly established functional connections from the brain to circuits below the spinal lesion as a source of control signals. The approach is thus designed to enable and facilitate the natural sensory input as well as supraspinal connections to the spinal cord in order to control movements, rather than induce the spinal cord to directly induce the movement. That is, we facilitate and enhance the intrinsic neural control mechanisms of the spinal cord that exist post-SCI, rather than replace or ignore them.
In various embodiments the methods and devices described herein exploit spinal control of locomotor activity. For example, the human spinal cord can receive sensory input associated with a movement such as stepping, and this sensory information can be used to modulate the motor output to accommodate the appropriate speed of stepping and level of load that is imposed on lower limbs. Moreover, we have demonstrated that the human lumbosacral spinal cord has central-pattern-generation-like properties. Thus, oscillations of the lower limbs can be induced simply by vibrating the vastus lateralis muscle of the lower limb, by transcutaneous stimulation, and by stretching the hip. The methods described herein exploit the fact that the human spinal cord, in complete or incomplete SCI subjects, can receive and interpret proprioceptive and somatosensory information that can be used to control the patterns of neuromuscular activity among the motor pools necessary to generate particular movements, e.g., standing, stepping, reaching, grasping, and the like. The methods described herein facilitate and adapt the operation of the existing spinal circuitry that generates, for example, cyclic step-like movements via a combined approach of transcutaneous stimulation, physical training, and, optionally, pharmacology.
Facilitating Stepping and Standing in Humans Following a Clinically Complete Lesion
Locomotion in mammals is attributed to intrinsic oscillating spinal neural networks capable of central pattern generation interacting with sensory information (Edgerton et al., J. American Paraplegia Soc, 14(4) (1991), 150-157; Forssberg, J. Neurophysiol, 42(4): 936-953 (1979); Grillner and Wallen, Annu. Rev. Neurosci., 8: 233-261 (1985); Grillner and Zangger, Exp Brain Res, 34(2): 241-261 (1979)). These networks play critical roles in generating the timing of the complex postural and rhythmic motor patterns executed by motor neurons.
As indicated above, the methods described herein can involve stimulation of one or more regions of the spinal cord in combination with locomotory activities. It was our discovery that spinal stimulation in combination with locomotor activity results in the modulation of the electrophysiological properties of spinal circuits in the subject so they are activated by Proprioceptive information derived from the region of the subject where locomotor activity is to be facilitated. Further, we also determined that spinal stimulation in combination with pharmacological agents and locomotor activity results in the modulation of the electrophysiological properties of spinal circuits in the subject so they are activated by proprioceptive information derived from the region of the subject where locomotor activity is to be facilitated.
Locomotor activity of the region of interest can be accomplished by any of a number of methods known, for example, to physical therapists. By way of illustration, individuals after severe SCI can generate standing and stepping patterns when provided with body weight support on a treadmill and manual assistance. During both stand and step training of human subjects with SCI, the subjects can be placed on a treadmill in an upright position and suspended in a harness at the maximum load at which knee buckling and trunk collapse can be avoided. Trainers positioned, for example, behind the subject and at each leg assist as needed in maintaining proper limb kinematics and kinetics appropriate for each specific task. During bilateral standing, both legs can be loaded simultaneously and extension can be the predominant muscular activation pattern, although co-activation of flexors can also occur. Additionally, or alternatively, during stepping the legs are loaded in an alternating pattern and extensor and flexor activation patterns within each limb also alternated as the legs moved from stance through swing. Afferent input related to loading and stepping rate can influence these patterns, and training has been shown to improve these patterns and function in clinically complete SCI subjects.
As indicated above, without being bound by a particular theory, it is believed that transcutaneous stimulation, e.g., over the throacic spinal cord in combination with physical training can facilitate recovery of stepping and standing in human subjects following a complete SCI.
Spinal cord electrical stimulation has been successfully used in humans for suppression of pain and spasticity (see, e.g., Johnson and Burchiel, Neurosurgery, 55(1): 135-141 (2004); discussion 141-142; Shealy et al., AnesthAnalg, 46(4): 489-491 (1967); Campos et al., Appl. Neurophysiol. 50(1-6): 453-454 (1987); Dimitrijevic and Sherwood, Neurology, 30 (7 Pt 2): 19-27 (1980); Barolat Arch. Med. Res., 31(3): 258-262 (2000); Barolat, J. Am. Paraplegia Soc., 11(1): 9-13 (1988); Richardson et al., Neurosurgery, 5(3): 344-348). Recent efforts to optimize stimulation parameters have led to a number of research studies focusing on the benefits of transcutaneous spinal cord stimulation. We have demonstrated that the location of the electrode and its stimulation parameters are important in defining the motor response. Use of surface electrode(s), as described herein, facilitates selection or alteration of particular stimulation sites as well as the application of a wide variety of stimulation parameters.
The following non-limiting examples are offered for illustrative purposes.
A noninvasive method for activating the SN by means of transcutaneous electrical spinal cord stimulation (tESCS) is demonstrated in this Example. The method is based on our research that showed that a single dermal electric stimulus applied in the region of the T11-T 12 vertebrae caused monosynaptic reflexes in the proximal and distal leg muscles in healthy subjects (see Courtine, G., Harkema S. J, Dy, C. J., Gerasimenko, Yu. P., and Dyhre-Poulsen, P., Modulation of Multisegmental Monosynaptic Responses in a Variety of Leg Muscles during Walking and Running in Humans, J Physiology, 2007, vol. 585, p. 1125) and in patients with clinically complete (ASIA A) spinal cord injury. See Dy, C. J., Gerasimenko, YP., Edgerton, V R., DyhrePoulsen P., Courtine G., Harkema S., Phase-Dependent Modulation of Percutaneously Elicited Multisegmental Muscle Responses after Spinal Cord Injury, J Neurophysiol., 2010, vol. 103, p. 2808. Taking into consideration that eESCS affects the SN through mono and polysynaptic reflexes (see Minassian, Persy, Rattay, Pinter, Kern, and Dimitrijevic, supra), we suggest that noninvasive tESCS can be an effective way to neuromodulate the SN.
Experiment
We examined six adult male subjects (students and staff of the Velikie Luki State Academy of Physical Education and Sports). They had given their informed written consent to participate in the experiment. The experiment was approved by the Ethics Committee of the academy and met the requirements of the Helsinki Declaration.
The subjects lay on a couch on their left side, with their feet placed on separate boards that were attached to a hook in the ceiling of the experimental room with ropes, like swings. The right (upper) leg was supported directly in the region of the shank. The left (lower) leg was placed in a rotating frame attached to a horizontal board. Under these conditions, the subjects could move their legs through maximum amplitude: According to the instructions, the subjects lay quietly and neither counteracted nor facilitated the movements caused by electrical stimulation of the spinal cord.
The tESCS was performed using a KULON stimulator (St. Petersburg State University of Aerospace Instrumentation, St. Petersburg, Russia). The stimulation was administered using a 2.5 cm round electrode (Lead-Lok, Sandpoint, United States) placed midline on the skin between the spinous processes of T11 and T12 as a cathode and two 5.0×10.2 cm rectangular plates made of conductive plastic (Ambu, Ballerup, Germany) placed symmetrically on the skin over the iliac crests as anodes. The step-like movements were evoked by a bipolar rectangular stimulus with a duration of 0.5 ms, filled with a carrier frequency of 10 kHz; the intensity of stimulation ranged from 30 to 100 mA. The stimulation frequencies were 1, 5, 10, 20, 30, and 40 Hz; the duration of exposure ranged from 10 to 30 s. During the high-frequency stimulation within each stimulus, tESCS did not cause pain even when the amplitude was increased to 100 mA or more; allowing us to study in detail the dependence of the elicited movements on the amplitude and frequency of the stimulus.
The EMGs of the muscles of both legs (m. rectus femoris, m. biceps femoris, m. tibialis anterior, and m. gastrocnemius) were recorded by means of bipolar surface electrodes. EMG signals were recorded using an ME 6000 16-channel telemetric electroneuromyograph (Mega Win, Finland). Flexion-extension movements in the knee joints were recorded using a goniometer.
The Qualisy video system (Sweden) was used to record the kinematic parameters of leg movements. Light-reflecting markers were attached to the pivot points of the body, which coincided with the rotational axis in the shoulder, hip, knee, and ankle joints. The angular movements in the hip joint were calculated from the location of markers on the lateral epicondyle of the humerus, trochanter, and lateral epicondyle of the femur. The markers that were attached to the trochanter, lateral epicondyle of the femur, and lateral ankle were used to describe the movements in the knee joint. The movements in the ankle joint were estimated by means of the markers located on the lateral epicondyle of the femur, lateral ankle, and the big toe. The reconstruction of movements in one whole step cycle was performed by means of special software. In order to record the movements of the foot tip, the marker was fixed on the big toe of the right foot.
The recording of EMG was synchronized with the recording of stepping kinematical parameters. The average cycle duration and the amplitudes of angular movements were calculated from 10-12 cycles. The duration of a step cycle was calculated on the basis of the interval between two maximum values of angular movements in the hip, knee, and ankle joints. The phase shift between the hip and knee joints was calculated from the interval between the maximum values of angular movements in these joints.
The statistical treatment of the data was performed using a standard software package.
Results
Transcutaneous electrical spinal cord stimulation with a frequency of 5-40 Hz elicited involuntary leg movements in five out of six subjects. The threshold intensity of the stimulus that induced involuntary movements was 50-60 mA and was dependent on the frequency of stimulation. The tESCS at a frequency of 1 Hz caused reflex responses in the leg muscles with a threshold of 70-80 mA (
Original records of EMG responses in the muscles of the right leg to the tESCS at a frequency of 1 Hz and intensity of 75-100 mA are shown in
Transcutaneous electrical spinal cord stimulation at frequencies in the entire range from 5 to 40 Hz caused step-like movements in five subjects (
Pair wise comparison of the mean amplitudes of the movements of the hip, knee, and ankle joints calculated during the first and the last 15 s of stimulation at each of the frequencies used allowed us to determine the probability of the differences in the amplitudes of the induced movements at the beginning and at the end of the stimulation (see Table 1, below). Two rows of probabilities for subject C, calculated on the bases of two experiments show the different direction of the changes in the amplitudes at the beginning and end of stimulation. In the table, the cases when the amplitude of movements at the end of the stimulation was significantly greater than in the beginning are boldfaced; the cases when the amplitude of movements at the end of the stimulation was significantly lower than in the beginning are italicized. According to the data, the subjects were divided into two groups. In the first group (subjects R and S), step-like movements were evoked by the stimulation at the entire range of the frequencies studied (5-40 Hz), and the amplitude of movements, while growing at the beginning of stimulation, decayed after its termination. In the second group (subjects K and S), the movements were evoked with difficulty and with a limited set of frequencies. These differences could be related both to the individual characteristics of the electrical conductivity of the skin and to characteristics of the spinal connections.
The involuntary movements of the legs caused by tESCS fully complied with the characteristics of stepping movements (
The table below shows the probability of similarity of the mean amplitudes of movements, measured in the first and the last 15 s during tESCS. For subject S., two different cases of stimulation are shown.
H
0.005
0.003
0.03
0.0003
H
0.01
0.0001
0.004
0.04
0.0001
0.002
0.0004
0.002
0.0006
0.002
0.001
H
0.05
0.007
0.0001
0.001
0.03
0.01
0.02
0.008
0.003
H
0.002
0.03
0.008
0.001
H
0.03
0.04
0.02
0.05
0.001
H
0.004
0.05
0.005
0.05
0.009
Stepping cycles in three joints of the right leg during voluntary stepping movements (
The frequency of step-like movements did not depend on the frequency of stimulation. The average periods of step-like movements in subjects R, S, K, B, and G were 2.72±0.14, 2.39±0.55, 2.42±0.15, 3.22±0.85, and 1.9±0.09 s, respectively.
As mentioned above, the pair wise comparison of the mean amplitudes of the movements in the hip, knee, and ankle joints calculated in the first and the last 15 s of stimulation in different subjects, showed that, regardless of the stimulation frequency, the amplitude of movements may either increase or decrease significantly. At the beginning of stimulation, there was a tendency for the amplitude of movements to increase with increasing frequency of stimulation in all subjects for all joints (
Note that, in the cases shown in
Recently, it was shown that transcutaneous electrical stimulation of the lumbar enlargement may facilitate passive walking movements on a moving treadmill and strengthen the patterns of EMG activity in leg muscles in patients with complete or partial spinal cord lesions. See Minassian, Persy, Rattay, Pinter, Kern, and Dimitrijevic, supra. However, involuntary step-like movements were never successfully evoked by means of transcutaneous stimulation in this category of patients before. The transcutaneous electrical stimulation applied to the rostral segments of the lumbar enlargement (in the region of the T11-T12 vertebrae) elicited involuntary step-like movements in healthy subjects with their legs suspended in a gravity-neutral position. This phenomenon was observed in five out of the six subjects studied. tESCS did not cause discomfort and was easily tolerated by subjects when biphasic stimuli filled with a carrier frequency of 10 kHz which suppressed the sensitivity of pain receptors were used.
It was found that a single transcutaneous electrical stimulation in the region of the T11-T12 vertebrae causes responses in leg muscles with a latency period corresponding to monosynaptic reflexes. See Courtine, Harkema, Dy, Gerasimenko, and Dyhre-Poulsen, supra. It is assumed that these responses are due to the activation of large-diameter dorsal root afferents. See Minassian, Persy, Rattay, Pinter, Kern, and Dimitrijevic, supra; Dy, C. J., Gerasimenko, Y P., Edgerton, V R., DyhrePoulsen P., Courtine G., Harkema S., Phase-Dependent Modulation of Percutaneously Elicited Multisegmental Muscle Responses after Spinal Cord Injury, J Neurophysiol., 2010, vol. 103, p. 2808; de Noordhout, A., Rothwell, J. e., Thompson, P. D., Day, B. L., and Marsden, e. D., Percutaneous Electrical Stimulation of Lumbosacral Roots in Man, J Neurol. Neurosurg. Psychiatry, 1988, vol. 51, p. 174; Troni, W., Bianco, e., Moja, M. C., and Dotta, M., Improved Methodology for Lumbosacral Nerve Root Stimulation, Afuscle Nerve, 1996, vol. 19, no. Iss. 5, p. 595; Dyhre-Poulsen, P., Dy, Courtine, G., Harkema, S., and Gerasimenko, Y U. P., Modulation of Multi segmental Monosynaptic Reflexes Recorded from Leg Muscles During Walking and Running in Human Subjects, Gait Posture, 2005, vol. 21, p. 66. The monosynaptic nature of these responses is confirmed by the fact that vibration of muscle tendons or paired stimulation suppresses the responses. We have previously shown that the responses to the second stimulus were suppressed in rats during epidural stimulation (see Gerasimenko, Lavrov, Courtine, Ronaldo, Ichiyama, Dy, Zhong, Roy, and Edgerton, supra) and in healthy humans (see Courtine, Harkema, Dy, Gerasimenko, and Dyhre-Poulsen, supra; Dy, Gerasimenko, Edgerton, Dyhre-Poulsen, Courtine, Harkema, supra) during paired tESCS with a delay between the stimuli of 50 ms. This refractory period excludes the possibility of direct activation of the motor neurons in the ventral horn or ventral root activation. See Struijk, 1.1., Holsheimer, 1., and Boom, H. B. K., Excitation of Dorsal Root Fibers in Spinal Cord Stimulation: A Theoretical Study, IEEE Trans. Biorned. Eng., 1993, vol. 40, no. 7, p. 632. The monosynaptic nature of the responses was also shown during vibration tests. It is well known that vibration suppresses monosynaptic reflex pathways in homologous muscles. See Mao, e.e., Ashby, P., Wang, M., and McCrea, D., Synaptic Connections from Large Muscle Afferents to the Motoneurons of Various Leg Muscles in Man, Exp. Brain Res., 1984, vol. 56, p. 341. The suppression of responses caused by tESCS in shin muscles during the vibration of the Achilles tendon directly shows the monosynaptic nature of these responses. The similarity of modulations of the classical monosynaptic H-reflex and reflex responses caused by tESCS during walking in healthy subjects (see Courtine, Harkema, Dy, Gerasimenko, and Dyhre-Poulsen, supra) and in patients with spinal cord injuries (see Dy, Gerasimenko, Edgerton, Dyhre-Poulsen, Courtine, Harkema, supra) also supports the monosynaptic nature of the responses to transcutaneous stimulation. In both cases, the amplitude of modulation of the reflexes was proportional and phase-dependent on the activation level of each muscle. All of the above data indicate the identity of the H-reflex and reflex responses induced by tESCS.
In the flexor muscles affected by tESCS, polysynaptic reflexes were sometimes recorded in addition to the monosynaptic component (
The previous experiments showed that the rostral segments of the lumbar spinal cord may play the role of triggers in initiating locomotor movements. See Deliagina, T. G., Orlovsky, G. N., and Pavlova, G. A., The Capacity for Generation of Rhythmic Oscillations Is Distributed in the Lumbosacral Spinal Cord of the Cat, Exp. Brain Res., 1983, vol. 53, p. 81. In spinal patients (see Dimitrijevic, M. R, Gerasimenko, Yu., and Pinter, M. M., Evidence for a Spinal Central Pattern Generator in Humans, Ann. N. Y. Acad. Sci., 1998, vol. 860, p. 360) and in spinal rats (Ichiyama, R. M., Gerasimenko, Y U. P., Zhong, H., Roy, R. R., and Edgerton VR., Hindlimb Stepping Movements in Complete Spinal Rats Induced by Epidural Spinal Cord Stimulation, New⋅osci. Lett., 2005, vol. 383, p. 339), step-like patterns of EMG activity were evoked by epidural stimulation of the L2 segment. In our experiments, we used transcutaneous electrical stimulation in the region of T11-T12 vertebrae, which corresponds to the cutaneous projection of the L2-L3 segments of the spinal cord. It was previously shown that the electromagnetic stimulation of this region in healthy subjects with their legs supported externally can initiate walking movements. See Gerasimenko, Gorodnichev, Machueva, Pivovarova, Semenov, Savochin, Roy, and Edgerton, supra; Gorodnichev, Machueva, Pivovarova, Semenov, Ivanov, Savokhin, Edgerton, and Gerasimenko, supra. These data are consistent with the current concept on the structural and functional organization of the SN with distributed pacemaking and pattern-generating systems (see McCrea, D. A. and Rybak, L A., Organization of Mammalian Locomotor Rhythm and Pattern Generation, Brain Res. Rev., 2008, vol. 57, no. 1, p. 134), in which the rostral lumbar segments of the spinal cord play the role of a trigger of the locomotor function.
The frequency of stimulation is an important characteristic of the motor output. It was shown that step-like movements are evoked by stimulation frequencies in the range of 5-40 Hz. The amplitude of step-like movements induced by high-frequency stimulation (30-40 Hz) was usually higher than that of the movements induced by low frequency stimulation (5 Hz), although the duration of the stepping cycle varied slightly. The fact that a wide range of frequencies can effectively induce step-like movements is probably due to the functional state of the intact spinal cord and its pathways. For example, in spinal patients, the effective frequency range for the initiation of step-like movements using epidural stimulation was 30-40 Hz (according to Dimitrijevic, Gerasimenko, and Pinter, supra); in decerebrated cats, the frequency of 5 Hz was the most effective to elicit locomotion (according to our data) (see Gerasimenko, Roy, and Edgerton, supra).
The intensity of transcutaneous electrical stimulation (50-80 mA) that causes step-like movements is approximately 10 times higher than the intensity of the epidural stimulation initiating walking movements in spinal patients. See Dimitrijevic, Gerasimenko, and Pinter, supra. If we assume that the dorsal roots are the main target for both types of stimulation, we should agree that the current should be strong to activate them by transcutaneous electrical stimulation. Thus, we conclude that the location, frequency, and intensity of stimulation are the factors that determine the activation of the SN by tESCS.
In most subjects, the involuntary step-like movements in the hip and knee joints were initiated by tESCS with a delay of 2-3 s after the start of stimulation. Typically, the amplitude of movements in the hip and knee joints increased smoothly and gradually with the subsequent involvement of the ankle joint (
In our studies, single pulse stimulation resulted in monosynaptic reflexes in the majority of the leg muscles investigated. However, the electromyographic trains evoked by continuous tESCS that induced involuntary step-like movements were not formed by the amplitude modulation of monosynaptic reflexes, as it was in spinal rats and during the spinal epidural stimulation of patients. See Gerasimenko, Roy, and Edgerton, supra. Our data showed that the activity within electromyographic trains was not stimulus-dependent; i.e., EMG trains did not consist of separate reflex responses. Similar stimulus-independent EMG trains were observed during involuntary movements caused by spinal cord electromagnetic stimulation. See Gerasimenko, Gorodnichev, Machueva, Pivovarova, Semenov, Savochin, Roy, and Edgerton, supra; Gorodnichev, Machueva, Pivovarova, Semenov, Ivanov, Savokhin, Edgerton, and Gerasimenko, supra. In contrast, the step-like movements evoked by the epidural spinal stimulation in rats and spinal patients were stimulus-dependent. See Gerasimenko, Roy, and Edgerton, supra. In the extensor muscles, the EMG trains consisted mainly of monosynaptic reflexes; in the flexor muscles, polysynaptic reflexes dominated in the EMG trains. See Gerasimenko, Y. P., Ichiyama, R. M., Lavrov, L A., Courtine, G. Cai, L., Zhong, H., Roy, R. R., and Edgerton, V. R., Epidural Spinal Cord Stimulation Plus Quipazine Administration Enable Stepping in Complete Spinal Adult Rats, J Neurophysiol., 2007, vol. 98, p. 2525; Minassian, K., Jilge, B., Rattay, F., Pinter, M. M., Binder, H., Gerstenbrand, F., and Dimitrijevic, M. R., Stepping-Like Movements in Humans with Complete Spinal Cord Injury Induced by Epidural Stimulation of the Lumbar Cord: Electromyographic Study of Compound Muscle Action Potentials, Spinal Cord 2004, vol. 42, p. 401. It is not clear why single cutaneous and, respectively, single epidural spinal cord stimulation causes the same monosynaptic reflexes in healthy subjects and spinal patients; however, continuous stimulation elicits their step-like movements through different mechanisms. We assume that, in healthy subjects, tESCS increases the excitability of the neuronal locomotor network, being a trigger for its activation, in the same way as in the case of vibration-induced step-like movements. See Selionov, Ivanenko, Solopova, and Gurfinkel', supra. However, we need additional studies to understand in detail how the tESCS elicits involuntary step-like movements.
In this study, a new noninvasive access to locomotor spinal neural networks in humans by means of tESCS has been described. A special design of the stimulator, which generated bipolar pulses filled with high-frequency carrier, allowed us to stimulate the spinal cord relatively painlessly and elicit involuntary step-like movements. The fundamental importance of our study consists in the new data in favor of the existence of SPGs in humans and the evidence of the possibility to control the SPGs using noninvasive effects on the structures of the spinal cord. This opens up good prospects for widespread use of transcutaneous techniques in electrical spinal cord stimulation to study the mechanisms underlying the regulation of the locomotor behavior in healthy subjects and for the rehabilitation and motor recovery of patients after spinal cord injuries.
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety for all purposes.
This application is a continuation of U.S. application Ser. No. 14/355,812 filed May 1, 2014, which is a U.S. 371 National Phase of PCT/US2012/064878, filed on Nov. 13, 2012, which claims the benefit of U.S. Provisional Application No. 61/558,892 filed Nov. 11, 2011, and U.S. Provisional Application No. 61/673,661 filed Jul. 19, 2012, both of which are incorporated by reference in their entirety. Additionally, U.S. patent application Ser. Nos. 13/342,903, 13/356,499, and 13/430,557 are incorporated by reference in their entirety.
This invention was made with Government support under NS062009, awarded by the National Institutes of Health. The Government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
3543761 | Bradley | Dec 1970 | A |
3662758 | Glover | May 1972 | A |
3724467 | Avery et al. | Apr 1973 | A |
4044774 | Corbin et al. | Aug 1977 | A |
4102344 | Conway et al. | Jul 1978 | A |
4141365 | Fischell et al. | Feb 1979 | A |
4285347 | Hess | Aug 1981 | A |
4340063 | Maurer | Jul 1982 | A |
4379462 | Borkan et al. | Apr 1983 | A |
4414986 | Dickhudt et al. | Nov 1983 | A |
4538624 | Tarjan | Sep 1985 | A |
4549556 | Tajan et al. | Oct 1985 | A |
4559948 | Liss et al. | Dec 1985 | A |
4800898 | Hess et al. | Jan 1989 | A |
4934368 | Lynch | Jun 1990 | A |
4969452 | Petrofsky et al. | Nov 1990 | A |
5002053 | Garcia-Rill et al. | Mar 1991 | A |
5031618 | Mullett | Jul 1991 | A |
5066272 | Eaton et al. | Nov 1991 | A |
5081989 | Graupe et al. | Jan 1992 | A |
5121754 | Mullett | Jun 1992 | A |
5344439 | Often | Sep 1994 | A |
5354320 | Schaldach et al. | Oct 1994 | A |
5374285 | Vaiani et al. | Dec 1994 | A |
5417719 | Hull et al. | May 1995 | A |
5476441 | Durfee et al. | Dec 1995 | A |
5562718 | Palermo | Oct 1996 | A |
5643330 | Holsheimer et al. | Jul 1997 | A |
5733322 | Starkebaum | Mar 1998 | A |
5983141 | Sluijter et al. | Nov 1999 | A |
6066163 | John | May 2000 | A |
6104957 | Alo et al. | Aug 2000 | A |
6122548 | Starkebaum et al. | Sep 2000 | A |
6308103 | Gielen | Oct 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6470213 | Alley | Oct 2002 | B1 |
6500110 | Davey et al. | Dec 2002 | B1 |
6503231 | Prausnitz et al. | Jan 2003 | B1 |
6505074 | Boveja et al. | Jan 2003 | B2 |
6551849 | Kenney | Apr 2003 | B1 |
6587724 | Mann | Jul 2003 | B2 |
6662053 | Borkan | Dec 2003 | B2 |
6666831 | Edgerton et al. | Dec 2003 | B1 |
6685729 | Gonzalez | Feb 2004 | B2 |
6819956 | DiLorenzo | Nov 2004 | B2 |
6839594 | Cohen et al. | Jan 2005 | B2 |
6871099 | Whitehurst et al. | Mar 2005 | B1 |
6892098 | Ayal et al. | May 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6895283 | Erickson et al. | May 2005 | B2 |
6937891 | Leinders et al. | Aug 2005 | B2 |
6950706 | Rodriguez et al. | Sep 2005 | B2 |
6975907 | Zanakis et al. | Dec 2005 | B2 |
6988006 | King et al. | Jan 2006 | B2 |
6999820 | Jordan | Feb 2006 | B2 |
7020521 | Brewer et al. | Mar 2006 | B1 |
7024247 | Gliner et al. | Apr 2006 | B2 |
7035690 | Goetz | Apr 2006 | B2 |
7047084 | Erickson et al. | May 2006 | B2 |
7065408 | Herman et al. | Jun 2006 | B2 |
7096070 | Jenkins et al. | Aug 2006 | B1 |
7110820 | Tcheng et al. | Sep 2006 | B2 |
7127287 | Duncan et al. | Oct 2006 | B2 |
7127296 | Bradley | Oct 2006 | B2 |
7127297 | Law et al. | Oct 2006 | B2 |
7153242 | Goffer | Dec 2006 | B2 |
7184837 | Goetz | Feb 2007 | B2 |
7200443 | Faul | Apr 2007 | B2 |
7209787 | DiLorenzo | Apr 2007 | B2 |
7228179 | Campen et al. | Jun 2007 | B2 |
7239920 | Thacker et al. | Jul 2007 | B1 |
7251529 | Greenwood-Van Meerveld | Jul 2007 | B2 |
7252090 | Goetz | Aug 2007 | B2 |
7313440 | Miesel et al. | Dec 2007 | B2 |
7324853 | Ayal et al. | Jan 2008 | B2 |
7330760 | Heruth et al. | Feb 2008 | B2 |
7337005 | Kim et al. | Feb 2008 | B2 |
7337006 | Kim et al. | Feb 2008 | B2 |
7381192 | Brodard et al. | Jun 2008 | B2 |
7415309 | Mcintyre | Aug 2008 | B2 |
7463928 | Lee et al. | Dec 2008 | B2 |
7467016 | Colborn | Dec 2008 | B2 |
7493170 | Segel et al. | Feb 2009 | B1 |
7496404 | Meadows et al. | Feb 2009 | B2 |
7502652 | Gaunt et al. | Mar 2009 | B2 |
7536226 | Williams et al. | May 2009 | B2 |
7544185 | Bengtsson | Jun 2009 | B2 |
7584000 | Erickson | Sep 2009 | B2 |
7590454 | Garabedian et al. | Sep 2009 | B2 |
7603178 | North et al. | Oct 2009 | B2 |
7628750 | Cohen et al. | Dec 2009 | B2 |
7660636 | Castel et al. | Feb 2010 | B2 |
7697995 | Cross et al. | Apr 2010 | B2 |
7729781 | Swoyer et al. | Jun 2010 | B2 |
7734340 | De Ridder | Jun 2010 | B2 |
7734351 | Testerman et al. | Jun 2010 | B2 |
7769463 | Katsnelson | Aug 2010 | B2 |
7797057 | Harris | Sep 2010 | B2 |
7801601 | Maschino et al. | Sep 2010 | B2 |
7813803 | Heruth et al. | Oct 2010 | B2 |
7813809 | Strother et al. | Oct 2010 | B2 |
7856264 | Firlik | Dec 2010 | B2 |
7877146 | Rezai et al. | Jan 2011 | B2 |
7890182 | Parramon | Feb 2011 | B2 |
7949395 | Kuzma | May 2011 | B2 |
7949403 | Palermo et al. | May 2011 | B2 |
7987000 | Moffitt et al. | Jul 2011 | B2 |
7991465 | Bartic et al. | Aug 2011 | B2 |
8019427 | Moffitt | Sep 2011 | B2 |
8050773 | Zhu | Nov 2011 | B2 |
8108052 | Boling | Jan 2012 | B2 |
8131358 | Moffitt et al. | Mar 2012 | B2 |
8155750 | Jaax et al. | Apr 2012 | B2 |
8170660 | Dacey, Jr. et al. | May 2012 | B2 |
8190262 | Gerber et al. | May 2012 | B2 |
8195304 | Strother et al. | Jun 2012 | B2 |
8214048 | Whitehurst et al. | Jul 2012 | B1 |
8229565 | Kim et al. | Jul 2012 | B2 |
8239038 | Wolf, II | Aug 2012 | B2 |
8260436 | Gerber et al. | Sep 2012 | B2 |
8271099 | Swanson | Sep 2012 | B1 |
8295936 | Wahlstrand et al. | Oct 2012 | B2 |
8311644 | Moffitt et al. | Nov 2012 | B2 |
8332029 | Glukhovsky et al. | Dec 2012 | B2 |
8346366 | Arle et al. | Jan 2013 | B2 |
8352036 | DiMarco et al. | Jan 2013 | B2 |
8355791 | Moffitt | Jan 2013 | B2 |
8355797 | Caparso et al. | Jan 2013 | B2 |
8364273 | De Ridder | Jan 2013 | B2 |
8369961 | Christman et al. | Feb 2013 | B2 |
8412345 | Moffitt | Apr 2013 | B2 |
8428728 | Sachs | Apr 2013 | B2 |
8442655 | Moffitt et al. | May 2013 | B2 |
8452406 | Arcot-Krishnamurthy et al. | May 2013 | B2 |
8588884 | Hegde et al. | Nov 2013 | B2 |
8700145 | Kilgard et al. | Apr 2014 | B2 |
8712546 | Kim et al. | Apr 2014 | B2 |
8750957 | Tang et al. | Jun 2014 | B2 |
8805542 | Tai et al. | Aug 2014 | B2 |
9072891 | Rao | Jul 2015 | B1 |
9101769 | Edgerton et al. | Aug 2015 | B2 |
9205259 | Kim et al. | Dec 2015 | B2 |
9205260 | Kim et al. | Dec 2015 | B2 |
9205261 | Kim et al. | Dec 2015 | B2 |
9272143 | Libbus et al. | Mar 2016 | B2 |
9283391 | Ahmed | Mar 2016 | B2 |
9393409 | Edgerton et al. | Jul 2016 | B2 |
9415218 | Edgerton et al. | Aug 2016 | B2 |
9610442 | Yoo et al. | Apr 2017 | B2 |
9993642 | Gerasimenko | Jun 2018 | B2 |
10137299 | Lu et al. | Nov 2018 | B2 |
20020055779 | Andrews | May 2002 | A1 |
20020111661 | Cross et al. | Aug 2002 | A1 |
20020115945 | Herman et al. | Aug 2002 | A1 |
20020193843 | Hill et al. | Dec 2002 | A1 |
20030032992 | Thacker et al. | Feb 2003 | A1 |
20030078633 | Firlik et al. | Apr 2003 | A1 |
20030100933 | Ayal et al. | May 2003 | A1 |
20030158583 | Burnett et al. | Aug 2003 | A1 |
20030220679 | Han | Nov 2003 | A1 |
20030233137 | Paul, Jr. | Dec 2003 | A1 |
20040039425 | Greenwood-Van Meerveld | Feb 2004 | A1 |
20040044380 | Bruninga et al. | Mar 2004 | A1 |
20040111118 | Hill et al. | Jun 2004 | A1 |
20040111126 | Tanagho et al. | Jun 2004 | A1 |
20040122483 | Nathan et al. | Jun 2004 | A1 |
20040127954 | McDonald et al. | Jul 2004 | A1 |
20040133248 | Frei et al. | Jul 2004 | A1 |
20040138518 | Rise et al. | Jul 2004 | A1 |
20050004622 | Cullen et al. | Jan 2005 | A1 |
20050070982 | Heruth et al. | Mar 2005 | A1 |
20050075669 | King | Apr 2005 | A1 |
20050075678 | Faul | Apr 2005 | A1 |
20050102007 | Ayal et al. | May 2005 | A1 |
20050113882 | Cameron et al. | May 2005 | A1 |
20050119713 | Whitehurst et al. | Jun 2005 | A1 |
20050125045 | Brighton et al. | Jun 2005 | A1 |
20050209655 | Bradley et al. | Sep 2005 | A1 |
20050246004 | Cameron et al. | Nov 2005 | A1 |
20050278000 | Strother et al. | Dec 2005 | A1 |
20060003090 | Rodger et al. | Jan 2006 | A1 |
20060041295 | Osypka | Feb 2006 | A1 |
20060089696 | Olsen et al. | Apr 2006 | A1 |
20060100671 | Ridder | May 2006 | A1 |
20060111754 | Rezai et al. | May 2006 | A1 |
20060122678 | Olsen et al. | Jun 2006 | A1 |
20060142816 | Fruitman et al. | Jun 2006 | A1 |
20060142822 | Tulgar | Jun 2006 | A1 |
20060149333 | Tanagho et al. | Jul 2006 | A1 |
20060149337 | John | Jul 2006 | A1 |
20060239482 | Hatoum | Oct 2006 | A1 |
20070016097 | Farquhar et al. | Jan 2007 | A1 |
20070016266 | Paul, Jr. | Jan 2007 | A1 |
20070049814 | Muccio | Mar 2007 | A1 |
20070055337 | Tanrisever | Mar 2007 | A1 |
20070060954 | Cameron et al. | Mar 2007 | A1 |
20070060980 | Strother et al. | Mar 2007 | A1 |
20070073357 | Rooney et al. | Mar 2007 | A1 |
20070083240 | Peterson et al. | Apr 2007 | A1 |
20070156179 | S.E. | Jul 2007 | A1 |
20070168008 | Olsen | Jul 2007 | A1 |
20070179534 | Firlik et al. | Aug 2007 | A1 |
20070191709 | Swanson | Aug 2007 | A1 |
20070208381 | Hill et al. | Sep 2007 | A1 |
20070233204 | Lima et al. | Oct 2007 | A1 |
20070255372 | Metzler et al. | Nov 2007 | A1 |
20070265679 | Bradley et al. | Nov 2007 | A1 |
20070265691 | Swanson | Nov 2007 | A1 |
20070276449 | Gunter et al. | Nov 2007 | A1 |
20070276450 | Meadows et al. | Nov 2007 | A1 |
20080021513 | Thacker et al. | Jan 2008 | A1 |
20080046049 | Skubitz et al. | Feb 2008 | A1 |
20080051851 | Lin | Feb 2008 | A1 |
20080071325 | Bradley | Mar 2008 | A1 |
20080103579 | Gerber | May 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080140169 | Imran | Jun 2008 | A1 |
20080147143 | Popovic et al. | Jun 2008 | A1 |
20080154329 | Pyles et al. | Jun 2008 | A1 |
20080183224 | Barolat | Jul 2008 | A1 |
20080200749 | Zheng et al. | Aug 2008 | A1 |
20080207985 | Farone | Aug 2008 | A1 |
20080215113 | Pawlowicz | Sep 2008 | A1 |
20080221653 | Agrawal et al. | Sep 2008 | A1 |
20080228241 | Sachs | Sep 2008 | A1 |
20080228250 | Mironer | Sep 2008 | A1 |
20080234791 | Arle et al. | Sep 2008 | A1 |
20080279896 | Heinen et al. | Nov 2008 | A1 |
20090012436 | Lanfermann et al. | Jan 2009 | A1 |
20090093854 | Leung et al. | Apr 2009 | A1 |
20090112281 | Miyazawa et al. | Apr 2009 | A1 |
20090118365 | Benson, III et al. | May 2009 | A1 |
20090157141 | Chiao et al. | Jun 2009 | A1 |
20090198305 | Naroditsky et al. | Aug 2009 | A1 |
20090204173 | Fang et al. | Aug 2009 | A1 |
20090270960 | Zhao et al. | Oct 2009 | A1 |
20090281599 | Thacker et al. | Nov 2009 | A1 |
20090299166 | Nishida et al. | Dec 2009 | A1 |
20090299167 | Seymour | Dec 2009 | A1 |
20090306491 | Haggers | Dec 2009 | A1 |
20100004715 | Fahey | Jan 2010 | A1 |
20100023103 | Elborno | Jan 2010 | A1 |
20100042193 | Slavin | Feb 2010 | A1 |
20100070007 | Parker et al. | Mar 2010 | A1 |
20100114239 | McDonald et al. | May 2010 | A1 |
20100125313 | Lee et al. | May 2010 | A1 |
20100137938 | Kishawi et al. | Jun 2010 | A1 |
20100145428 | Cameron et al. | Jun 2010 | A1 |
20100152811 | Flaherty | Jun 2010 | A1 |
20100185253 | Dimarco et al. | Jul 2010 | A1 |
20100198298 | Glukhovsky et al. | Aug 2010 | A1 |
20100217355 | Tass et al. | Aug 2010 | A1 |
20100241191 | Testerman et al. | Sep 2010 | A1 |
20100268299 | Farone | Oct 2010 | A1 |
20100274312 | Alataris et al. | Oct 2010 | A1 |
20100305660 | Hegi et al. | Dec 2010 | A1 |
20100318168 | Bighetti | Dec 2010 | A1 |
20100331925 | Peterson | Dec 2010 | A1 |
20110029040 | Walker et al. | Feb 2011 | A1 |
20110040349 | Graupe | Feb 2011 | A1 |
20110054567 | Lane et al. | Mar 2011 | A1 |
20110054568 | Lane et al. | Mar 2011 | A1 |
20110054579 | Kumar et al. | Mar 2011 | A1 |
20110125203 | Simon et al. | May 2011 | A1 |
20110130804 | Lin et al. | Jun 2011 | A1 |
20110152967 | Simon et al. | Jun 2011 | A1 |
20110160810 | Griffith | Jun 2011 | A1 |
20110166546 | Jaax et al. | Jul 2011 | A1 |
20110184488 | De Ridder | Jul 2011 | A1 |
20110184489 | Nicolelis et al. | Jul 2011 | A1 |
20110218594 | Doran et al. | Sep 2011 | A1 |
20110224665 | Crosby et al. | Sep 2011 | A1 |
20110224752 | Rolston et al. | Sep 2011 | A1 |
20110224753 | Palermo et al. | Sep 2011 | A1 |
20110224757 | Zdeblick et al. | Sep 2011 | A1 |
20110230701 | Simon et al. | Sep 2011 | A1 |
20110245734 | Wagner et al. | Oct 2011 | A1 |
20110276107 | Simon et al. | Nov 2011 | A1 |
20110288609 | Tehrani et al. | Nov 2011 | A1 |
20110295100 | Rolston et al. | Dec 2011 | A1 |
20120006793 | Swanson | Jan 2012 | A1 |
20120029528 | Macdonald et al. | Feb 2012 | A1 |
20120035684 | Thompson et al. | Feb 2012 | A1 |
20120101326 | Simon et al. | Apr 2012 | A1 |
20120109251 | Lebedev et al. | May 2012 | A1 |
20120109295 | Fan | May 2012 | A1 |
20120123293 | Shah et al. | May 2012 | A1 |
20120126392 | Kalvesten et al. | May 2012 | A1 |
20120165899 | Gliner | Jun 2012 | A1 |
20120172946 | Altaris et al. | Jul 2012 | A1 |
20120179222 | Jaax et al. | Jul 2012 | A1 |
20120185020 | Simon | Jul 2012 | A1 |
20120197338 | Su et al. | Aug 2012 | A1 |
20120221073 | Southwell et al. | Aug 2012 | A1 |
20120232615 | Barolat et al. | Sep 2012 | A1 |
20120252874 | Feinstein et al. | Oct 2012 | A1 |
20120259380 | Pyles | Oct 2012 | A1 |
20120277824 | Li | Nov 2012 | A1 |
20120277834 | Mercanzini et al. | Nov 2012 | A1 |
20120283697 | Kim et al. | Nov 2012 | A1 |
20120283797 | De Ridder | Nov 2012 | A1 |
20120302821 | Burnett | Nov 2012 | A1 |
20120310305 | Kaula et al. | Dec 2012 | A1 |
20120310315 | Savage et al. | Dec 2012 | A1 |
20120330391 | Bradley et al. | Dec 2012 | A1 |
20130013041 | Glukhovsky et al. | Jan 2013 | A1 |
20130030319 | Hettrick et al. | Jan 2013 | A1 |
20130030501 | Feler et al. | Jan 2013 | A1 |
20130053734 | Barriskill et al. | Feb 2013 | A1 |
20130066392 | Simon et al. | Mar 2013 | A1 |
20130085317 | Feinstein | Apr 2013 | A1 |
20130110196 | Alataris et al. | May 2013 | A1 |
20130123568 | Hamilton et al. | May 2013 | A1 |
20130123659 | Bartol et al. | May 2013 | A1 |
20130165991 | Kim et al. | Jun 2013 | A1 |
20130197408 | Goldfarb et al. | Aug 2013 | A1 |
20130253299 | Weber et al. | Sep 2013 | A1 |
20130253611 | Lee et al. | Sep 2013 | A1 |
20130268016 | Xi et al. | Oct 2013 | A1 |
20130268021 | Moffitt | Oct 2013 | A1 |
20130281890 | Mishelevich | Oct 2013 | A1 |
20130289446 | Stone et al. | Oct 2013 | A1 |
20130303873 | Voros et al. | Nov 2013 | A1 |
20130304159 | Simon et al. | Nov 2013 | A1 |
20130310911 | Tai et al. | Nov 2013 | A1 |
20140031893 | Walker et al. | Jan 2014 | A1 |
20140046407 | Ben-Ezra et al. | Feb 2014 | A1 |
20140058490 | DiMarco | Feb 2014 | A1 |
20140066950 | Macdonald et al. | Mar 2014 | A1 |
20140067007 | Drees et al. | Mar 2014 | A1 |
20140067354 | Kaula et al. | Mar 2014 | A1 |
20140081071 | Simon et al. | Mar 2014 | A1 |
20140100633 | Mann et al. | Apr 2014 | A1 |
20140107397 | Simon et al. | Apr 2014 | A1 |
20140107398 | Simon et al. | Apr 2014 | A1 |
20140114374 | Rooney et al. | Apr 2014 | A1 |
20140163640 | Edgerton et al. | Jun 2014 | A1 |
20140180361 | Burdick et al. | Jun 2014 | A1 |
20140213842 | Simon et al. | Jul 2014 | A1 |
20140236257 | Parker et al. | Aug 2014 | A1 |
20140296752 | Edgerton et al. | Oct 2014 | A1 |
20140303901 | Sadeh | Oct 2014 | A1 |
20140316484 | Edgerton et al. | Oct 2014 | A1 |
20140316503 | Tai et al. | Oct 2014 | A1 |
20140324118 | Simon et al. | Oct 2014 | A1 |
20140330067 | Jordan | Nov 2014 | A1 |
20140330335 | Errico et al. | Nov 2014 | A1 |
20140357936 | Simon et al. | Dec 2014 | A1 |
20150065559 | Feinstein et al. | Mar 2015 | A1 |
20150165226 | Simon et al. | Jun 2015 | A1 |
20150182784 | Barriskill et al. | Jul 2015 | A1 |
20150190634 | Rezai et al. | Jul 2015 | A1 |
20150231396 | Burdick et al. | Aug 2015 | A1 |
20150265830 | Simon et al. | Sep 2015 | A1 |
20160030737 | Gerasimenko et al. | Feb 2016 | A1 |
20160030748 | Edgerton et al. | Feb 2016 | A1 |
20160045727 | Rezai et al. | Feb 2016 | A1 |
20160045731 | Simon et al. | Feb 2016 | A1 |
20160074663 | De Ridder | Mar 2016 | A1 |
20160121109 | Edgerton et al. | May 2016 | A1 |
20160121114 | Simon et al. | May 2016 | A1 |
20160121116 | Simon et al. | May 2016 | A1 |
20160175586 | Edgerton et al. | Jun 2016 | A1 |
20160220813 | Edgerton et al. | Aug 2016 | A1 |
20160235977 | Lu et al. | Aug 2016 | A1 |
20160339239 | Yoo et al. | Nov 2016 | A1 |
20170157389 | Tai et al. | Jun 2017 | A1 |
20170165497 | Lu | Jun 2017 | A1 |
20170246450 | Liu et al. | Aug 2017 | A1 |
20170246452 | Liu et al. | Aug 2017 | A1 |
20170274209 | Edgerton et al. | Sep 2017 | A1 |
20170296837 | Jin | Oct 2017 | A1 |
20180185642 | Lu | Jul 2018 | A1 |
20180256906 | Pivonka et al. | Sep 2018 | A1 |
20180280693 | Edgerton et al. | Oct 2018 | A1 |
20180361146 | Gerasimenko et al. | Dec 2018 | A1 |
20190022371 | Chang et al. | Jan 2019 | A1 |
20190167987 | Lu et al. | Jun 2019 | A1 |
20190381313 | Lu | Dec 2019 | A1 |
Number | Date | Country |
---|---|---|
2012204526 | Jul 2013 | AU |
2 823 592 | Jul 2012 | CA |
2661307 | Nov 2013 | EP |
2968940 | Jan 2016 | EP |
2130326 | May 1999 | RU |
2141851 | Nov 1999 | RU |
2160127 | Dec 2000 | RU |
2178319 | Jan 2002 | RU |
2192897 | Nov 2002 | RU |
2001102533 | Nov 2002 | RU |
2226114 | Mar 2004 | RU |
2258496 | Aug 2005 | RU |
2361631 | Jul 2009 | RU |
2368401 | Sep 2009 | RU |
2387467 | Apr 2010 | RU |
2396995 | Aug 2010 | RU |
2397788 | Aug 2010 | RU |
2445990 | Mar 2012 | RU |
2471518 | Jan 2013 | RU |
2475283 | Feb 2013 | RU |
WO 97047357 | Dec 1997 | WO |
WO 03026735 | Apr 2003 | WO |
WO 03092795 | Nov 2003 | WO |
WO 2004087116 | Oct 2004 | WO |
WO 2005051306 | Jun 2005 | WO |
WO 2005087307 | Sep 2005 | WO |
WO 2007007058 | Jan 2007 | WO |
WO 2007107831 | Sep 2007 | WO |
WO 2008109862 | Sep 2008 | WO |
WO 2008121891 | Oct 2008 | WO |
WO 2009042217 | Apr 2009 | WO |
WO 2009111142 | Sep 2009 | WO |
WO 2010055421 | May 2010 | WO |
WO 2010114998 | Oct 2010 | WO |
WO 2010124128 | Oct 2010 | WO |
WO 2012094346 | Jul 2012 | WO |
WO 2012100260 | Jul 2012 | WO |
WO 2012129574 | Sep 2012 | WO |
WO 2013071307 | May 2013 | WO |
WO 2013071309 | May 2013 | WO |
WO 2014144785 | Sep 2014 | WO |
WO 2015048563 | Apr 2015 | WO |
WO 2016029159 | Feb 2016 | WO |
WO 2016033369 | Mar 2016 | WO |
WO 2016033372 | Mar 2016 | WO |
WO 2017011410 | Jan 2017 | WO |
WO 2017024276 | Feb 2017 | WO |
WO 2017035512 | Mar 2017 | WO |
WO 2017044904 | Mar 2017 | WO |
WO 2018140531 | Aug 2018 | WO |
WO 2018217791 | Nov 2018 | WO |
WO 2020041502 | Feb 2020 | WO |
WO 2020041633 | Feb 2020 | WO |
Entry |
---|
U.S. Office Action dated Apr. 8, 2015 issued in U.S. Appl. No. 14/355,812. |
U.S. Final Office Action dated Sep. 21, 2015 issued in U.S. Appl. No. 14/355,812. |
U.S. Notice of Allowance dated Apr. 13, 2016 issued in U.S. Appl. No. 14/355,812. |
U.S. Office Action dated Jul. 13, 2016 issued in U.S. Appl. No. 14/775,618. |
PCT International Search Report dated Jul. 30, 2012 issued in PCT/US2012/020112. |
PCT International Preliminary Report on Patentability and Written Opinion dated Jul. 10, 2013 issued in PCT/US2012/020112. |
PCT International Search Report and Written Opinion dated Mar. 19, 2013 issued in PCT/US2012/064878. |
PCT International Preliminary Report on Patentability dated May 22, 2014 issued in PCT/US2012/064878. |
Australian Patent Examination Report No. 1 dated Jul. 11, 2016 issued in AU 2012334926. |
European Communication pursuant to Rule 114(2) EPC regarding observations by a third party dated Mar. 27, 2015 issued in EP 12 847 885.6. |
European Extended Search Report dated May 6, 2015 issued in EP 12 847 885.6. |
European Office Action dated Apr. 15, 2016 issued in EP 12 847 885.6. |
European Reply to Communication of Apr. 15, 2016 dated Oct. 24, 2016 in EP 12 847 885.6. |
European Second Office Action dated Feb. 16, 2017 issued in EP 12 847 885.6. |
PCT Declaration of Non-Establishment of International Search Report and Written Opinion dated Dec. 24, 2014 issued in PCT/US2014/057886. |
PCT International Preliminary Report on Patentability and Written Opinion dated Apr. 7, 2016 issued in PCT/US2014/057886. |
PCT International Search Report and Written Opinion dated Aug. 6, 2014 issued in PCT/US2014/029340. |
PCT International Preliminary Report on Patentability dated Sep. 24, 2015 issued in PCT/US2014/029340. |
European Extended Search Report dated Nov. 8, 2016 issued in EP 14 76 5477.6. |
PCT International Search Report and Written Opinion dated Dec. 5, 2016 issued in PCT/US2016/045898. |
PCT International Search Report and Written Opinion dated Dec. 8, 2015 issued in PCT/US2015/047268. |
PCT International Preliminary Report on Patentability and Written Opinion dated Feb. 28, 2017 issued in PCT/US2015/047268. |
PCT International Search Report and Written Opinion dated Dec. 3, 2015 issued in PCT/US2015/047272. |
PCT International Preliminary Report on Patentability and Written Opinion dated Feb. 28, 2017 issued in PCT/US2015/047272. |
PCT Declaration of Non-Establishment of International Search Report and Written Opinion dated Dec. 1, 2015 issued in PCT/US2015/046378. |
PCT International Preliminary Report on Patentability and Written Opinion dated Feb. 21, 2017 issued in PCT/US2015/046378. |
PCT International Search Report and Written Opinion dated Dec. 5, 2016 issued in PCT/US2016/049129. |
PCT International Search Report dated Mar. 19, 2013 issued in PCT/US2012/064874. |
PCT International Search Report dated Mar. 19, 2013 issued in PCT/US2012/064878. |
PCT International Search Report dated Sep. 3, 2012 issued in PCT/US2012/022257. |
PCT International Search Report dated Oct. 31, 2012 issued in PCT/US2012/030624. |
Angeli et al. (2014) “Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans” Brain 137: 1394-1409. |
Courtine, Grégoire et al. (2007) “Modulation of multisegmental monosynaptic responses in a variety of leg muscles during walking and miming in humans,” J Physiol. 582.3:1125-1139. |
Danner S.M., Hofstoetter U.S., Ladenbauer J., Rattay F., and Minassian K. (Mar. 2011) “Can the human lumbar posterior columns be stimulated by transcutaneous spinal cord stimulation? A modeling study” Europe PMC Funders Author Manuscripts, Artif Organs 35(3):257-262, 12 pp. |
DeSantana et al. (Dec. 2008) “Effectiveness of Transcutaneous Electrical Nerve Stimulation for Treatment of Hyperalgesia and Pain,” Curr Rheumatol Rep. 10(6):492-499, 12 pp. |
Dubinsky, Richard M. and Miyasaki, Janis, “Assessment: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review),” Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, (2010) Neurology, 74:173-176. |
Fong et al. (2009) “Recovery of control of posture and locomotion after a spinal cord injury: solutions staring us in the face,” Progress in Brain Research, Elsevier Amsterdam, NL,175:393-418. |
Ganley et al., (2005) “Epidural Spinal Cord Stimulation Improves Locomoter Performance in Low ASIA C, Wheelchair-Dependent, Spinal Cord-Injured Individuals: Insights from Metabolic Response,” Top. Spinal Cord Inj. Rehabil;11(2):50-63. |
Gerasimenko Y., Gorodnichev R., Machueva E., Pivovarova E., Semyenov D., Savochin A., Roy R.R., and Edgerton V.R., (Mar. 10, 2010) “Novel and Direct Access to the Human Locomotor Spinal Circuitry,” J Neurosci. 30(10):3700-3708, PMC2847395. |
Gerasimenko Y.P., Ichiyama R.M., Lavrov I.A., Courtine G., Cai L., Zhong H., Roy R.R., and Edgerton V.R. (2007) “Epidural Spinal Cord Stimulation Plus Quipazine Administration Enable Stepping in Complete Spinal Adult Rats,” J Neurophysiol. 98:2525-2536. |
Harkema et al. (2011) “Effect of Epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study” Lancet 377(9781): 1938-1947; NIH Public Access Author Manuscript 17 pages [doi:10.1016/S0140-6736(11)60547-3]. |
Herman R., He J., D'Luzansky S., Willis W., Dilli S., (2002) “Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured,” Spinal Cord. 40:65-68. |
Hofstoetter, U.S. et al. (Aug. 2008) “Modification of Reflex Responses to Lumbar Posterior Root Stimulation by Motor Tasks in Healthy Subjects,” Artif Organs, 32(8):644-648. |
Ichiyama et al. (2005) “Hindlimb stepping movements in complete spinal rats induced by epidural spinal cord stimulation” Neuroscience Letters, 383:339-344. |
Kitano K., Koceja D.M. (2009) “Spinal reflex in human lower leg muscles evoked by transcutaneous spinal cord stimulation,” J Neurosci Methods. 180:111-115. |
Minasian et al. (2010) “Transcutaneous stimulation of the human lumbar spinal cord: Facilitating locomotor output in spinal cord injury,” Conf. Proceedings Soc. for Neurosci., Abstract No. 286.19, 1 page. |
Minassian et al. (Aug. 2011) “Transcutaneous spinal cord stimulation,” International Society for Restorative Neurology, http://restorativeneurology.org/resource-center/assessments/transcutaneous-lumbar-spinal-cord-stimulation/;http://restorativeneurology.org/wp-content/uploads/2011/08/Transcutaneous-spinal-cord-stimulation_long.pdf, 6 pp. |
Minassian et al. (Mar. 2007) “Posterior root-muscle reflexes elicited by transcutaneous stimulation of the human lumbosacral cord,” Muscle & Nerve 35:327-336. |
Nandra et al., (2014) “Microelectrode Implants for Spinal Cord Stimulation in Rats,” Thesis, California Institute of Technology, Pasadena, California, Defended on Sep. 24, 2014, 104 pages. |
Nandra et al., (Jan. 23, 2011) “A Parylene-Based Microelectrode Arrary Implant for Spinal Cord Stimulation in Rats,” Conf. Proc. IEEE Eng. Med. Biol. Soc., pp. 1007-1010. |
Rodger et al., (2007) “High Density Flexible Parylene-Based Multielectrode Arrays for Retinal and Spinal Cord Stimulation,” Transducers & Eurosensors, Proc. of the 14th International Conference on Solid-State Sensors, Actuators and Microsystems, Lyon, France, Jun. 10-14, 2007, IEEE, pp. 1385-1388. |
Seifert et al. (Nov. 1, 2002) “Restoration of Movement Using Functional Electrical Stimulation and Bayes' Theorem,” The Journal of Neuroscience, 22(1):9465-9474. |
Tanabe et al. (2008) “Effects of transcutaneous electrical stimulation combined with locomotion-like movement in the treatment of post-stroke gait disorder: a single-case study,” 30(5):411-416 abstract, 1 page. |
Ward, Alex R. (Feb. 2009) “Electrical Stimulation Using Kilohertz-Frequency Alternating Current,” (2009) Phys Ther.89(2):181-190 [published online Dec. 18, 2008]. |
U.S. Office Action dated Oct. 3, 2017 issued in U.S. Appl. No. 15/025,201. |
U.S. Final Office Action dated Apr. 25, 2017 issued in U.S. Appl. No. 14/775,618. |
U.S. Notice of Allowance dated Jan. 18, 2018 issued in U.S. Appl. No. 14/775,618. |
European Extended Search Report dated May 10, 2017 issued in EP 14849355.4. |
Australian Patent Examination Report No. 1 dated May 11, 2018 issued in AU 2014228794. |
PCT International Preliminary Report on Patentability and Written Opinion dated Feb. 15, 2018 issued in PCT/US2016/045898. |
European Extended Search Report dated Mar. 1, 2018 issued in EP 15836927.2. |
European Extended Search Report dated Apr. 4, 2018 issued in EP 15834593.4. |
PCT International Search Report and Written Opinion dated Sep. 12, 2016 issued in PCT/US2016/041802. |
PCT International Preliminary Report on Patentability and Written Opinion dated Jan. 25, 2018 issued in PCT/US2016/041802. |
PCT International Preliminary Report on Patentability and Written Opinion dated Mar. 8, 2018 issued in PCT/US2016/049129. |
U.S. Notice of Allowance dated Aug. 1, 2018 issued in U.S. Appl. No. 15/025,201. |
Canadian Office Action dated Aug. 31, 2018 issued in CA 2,864,473. |
Australian Examination report No. 1 dated Jan. 11, 2019 issued in AU 2014324660. |
European Office Action dated Jul. 20, 2018 issued in EP 14849355.4. |
European Office Action dated Nov. 14, 2018 issued in EP 14 76 5477.6. |
European Extended Search Report dated Dec. 13, 2018 issued in EP 16833973.7. |
PCT International Search Report and Written Opinion dated Mar. 12, 2018 issued in PCT/US2018/015098. |
PCT International Search Report and Written Opinion dated Aug. 31, 2018 issued in PCT/US2018/033942. |
U.S. Office Action dated Jul. 22, 2019 issued in U.S. Appl. No. 15/506,696. |
U.S. Office Action dated Jun. 4, 2019 issued in U.S. Appl. No. 15/505,053. |
U.S. Office Action dated Apr. 17, 2019 issued in U.S. Appl. No. 15/344,381. |
Canadian Office Action dated Jul. 30, 2019 issued in CA 2,864,473. |
European Office Action dated Sep. 27, 2019 issued in EP 14765477.6. |
Australian Patent Examination Report No. 1 dated Jul. 18, 2019 issued in AU 2015308779. |
Australian Patent Examination Report No. 1 dated Jun. 14, 2019 issued in AU 2015305237. |
European Office Action dated Jul. 17, 2019 issued in EP 15834593.4. |
European Extended Search Report dated Feb. 19, 2019 issued in EP 16825005.8. |
PCT International Preliminary Report on Patentability and Written Opinion dated Jul. 30, 2019 issued in PCT/US2018/015098. |
Andersson, et al., (2003) “CNS Involvement in Overactive Bladder.” Drugs, 63(23): 2595-2611. |
Edgerton and Harkema (2011) “Epidural stimulation of the spinal cord in spinal cord injury: current status and future challenges” Expert Rev Neurother. 11(10): 1351-1353. doi:10.1586/ern.11.129 [NIH Public Access—Author Manuscript—5 pages]. |
U.S. Office Action dated Jan. 8, 2020 issued in U.S. Appl. No. 15/975,678. |
U.S. Office Action dated Oct. 31, 2019 issued in U.S. Appl. No. 15/750,499. |
U.S. Notice of Allowance dated Feb. 13, 2020 issued in U.S. Appl. No. 15/505,053. |
U.S. Final Office Action dated Dec. 30, 2019 issued in U.S. Appl. No. 15/344,381. |
Australian Examination report No. 2 dated Nov. 7, 2019 issued in AU 2014324660. |
Australian Examination report No. 3 dated Jan. 6, 2020 issued in AU 2014324660. |
Australian Patent Examination Report No. 1 dated Jan. 6, 2020 issued in AU 2019206059. |
PCT International Preliminary Report on Patentability and Written Opinion dated Nov. 26, 2019 issued in PCT/US2018/033942. |
PCT International Search Report and Written Opinion dated Nov. 14, 2019 issued in PCT/US2019/047777. |
PCT International Search Report and Written Opinion dated Nov. 21, 2019 issued in PCT/US2019/047551. |
Kapetanakis, et al. (2017) “Cauda Equina Syndrome Due to Lumbar Disc Herniation: a Review of Literature,” Folia Medial, 59(4): 377-86. |
Wang, et al. (2017) “Incidence of C5 nerve root palsy after cervical surgery,” Medicine, 96(45), 14 pages. |
Number | Date | Country | |
---|---|---|---|
20170007831 A1 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
61558892 | Nov 2011 | US | |
61673661 | Jul 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14355812 | US | |
Child | 15208529 | US |